Jennifer A Woyach (Jennifer Woyach)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 58

Top Topics

Atrial Fibrillation

Direct Oral Anticoagulants

Top Venues

Nature communications

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennifer A Woyach, Jacqueline C Barrientos
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis. American journal of hematology 99 (4) (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Maria Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: Pooled analysis of 5 clinical trials. Blood advances (2024)
Bita Fakhri, Victoria Wang, Gabriela Perez-Burbano, Anna Wall, Sumithra Mandrekar, Sameer A Parikh, Jennifer A Woyach, Tait Shanafelt
Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trials. British journal of haematology (2024)
Jennifer A Woyach, Gabriela E Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Nancy L Bartlett, Danielle M Brander, Paul M Barr, Kerry A Rogers, Sameer A Parikh, Deborah M Stephens, Jennifer R Brown, Gerard Lozanski, James S Blachly, Sreenivasa Nattam, Richard A Larson, Harry P Erba, Mark R Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S Abramson, Richard F Little, Shira Dinner, Richard M Stone, Geoffrey L Uy, Wendy Stock, Sumithra J Mandrekar, John C Byrd
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood 143 (16) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Jennifer A Woyach, Gabriela E Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Nancy L Bartlett, Danielle M Brander, Paul M Barr, Kerry A Rogers, Sameer A Parikh, Deborah M Stephens, Jennifer R Brown, Gerard Lozanski, James S Blachly, Sreenivasa Nattam, Richard A Larson, Harry P Erba, Mark R Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S Abramson, Richard F Little, Shira Dinner, Richard M Stone, Geoffrey L Uy, Wendy Stock, Sumithra J Mandrekar, John C Byrd
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood 143 (16) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia 38 (3) (2024)
Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennifer A Woyach, Jacqueline C Barrientos
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis. American journal of hematology 99 (4) (2024)
Jennifer A Woyach, Gabriela E Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Nancy L Bartlett, Danielle M Brander, Paul M Barr, Kerry A Rogers, Sameer A Parikh, Deborah M Stephens, Jennifer R Brown, Gerard Lozanski, James S Blachly, Sreenivasa Nattam, Richard A Larson, Harry P Erba, Mark R Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S Abramson, Richard F Little, Shira Dinner, Richard M Stone, Geoffrey L Uy, Wendy Stock, Sumithra J Mandrekar, John C Byrd
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood 143 (16) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra, Mussammat Ferdousi, Onaopepo Kola-Kehinde, Patrick Ruz, Adam S Kittai, Kerry Rogers, Michael R Grever, Seema Bhat, Tracy Wiczer, John C Byrd, Jennifer A Woyach, Daniel Addison
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation. Leukemia (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia 38 (3) (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia 38 (3) (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennifer A Woyach, Jacqueline C Barrientos
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis. American journal of hematology (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia 38 (3) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennifer A Woyach, Jacqueline C Barrientos
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis. American journal of hematology 99 (4) (2024)
Jennifer A Woyach, Daniel Jones, Wojciech Jurczak, Tadeusz Robak, Arpad Illes, Arnon P Kater, Paolo Ghia, John C Byrd, John Francis Seymour, Susan Long, Nehad Mohamed, Samon Benrashid, Tzung-Huei Lai, Gary De Jesus, Richard Lai, Gerjan de Bruin, Simon Rule, Veerendra Munugalavadla
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib. Blood (2024)
Matthew R Avenarius, Ying Huang, Adam S Kittai, Seema A Bhat, Kerry A Rogers, Michael R Grever, Jennifer A Woyach, Cecelia R Miller
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia. Leukemia 38 (3) (2024)
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B Cempre, Fiona Brown, Porsha L Smith, Claudio Agostinelli, Stefano A Pileri, Jordan N Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P Beaver, Alexander Pan, Kyle Shin, Charles T Gregory, Gulcin H Ozer, Selen A Yilmaz, Bonnie K Harrington, Amy M Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly S Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer A Woyach, James S Blachly, Lapo Alinari, Yiping Yang, John C Byrd, Robert A Baiocchi, Bradley W Blaser, Rosa Lapalombella
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. Nature communications 14 (1) (2023)
Jennifer A Woyach, Deborah M Stephens, Ian W Flinn, Seema A Bhat, Ronald E Savage, Feng Chai, Sudharshan Eathiraj, Sean D Reiff, Elizabeth M Muhowski, Lindsey Granlund, Lyndsey Szuszkiewicz, Wayne Wang, Brian Schwartz, Razi Ghori, Mohammed Z H Farooqui, John C Byrd
First in Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma. Cancer discovery (2023)
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A Burger
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 15 (2) (2023)
Giovanna Merchand-Reyes, Ramasamy Santhanam, Maria L Valencia-Pena, Krishan Kumar, Xiaokui Mo, Tesfaye Belay, Jennifer A Woyach, Bethany Mundy-Bosse, Susheela Tridandapani, Jonathan P Butchar
Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia. Nutrients 15 (24) (2023)
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A Burger
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 15 (2) (2023)
Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, Susan M O'Brien, Daniel M Jones, Leo W K Cheung, Elizabeth Chong, Kevin Kwei, James P Dean, Danelle F James, Adrian Wiestner
B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B Cempre, Fiona Brown, Porsha L Smith, Claudio Agostinelli, Stefano A Pileri, Jordan N Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P Beaver, Alexander Pan, Kyle Shin, Charles T Gregory, Gulcin H Ozer, Selen A Yilmaz, Bonnie K Harrington, Amy M Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly S Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer A Woyach, James S Blachly, Lapo Alinari, Yiping Yang, John C Byrd, Robert A Baiocchi, Bradley W Blaser, Rosa Lapalombella
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. Nature communications 14 (1) (2023)
Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, Jennifer A Woyach, Adam S Kittai
Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy. Leukemia (2023)
Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, Jennifer A Woyach, Adam S Kittai
Evaluation of bleeding events in patients receiving acalabrutinib therapy. Leukemia (2023)
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B Cempre, Fiona Brown, Porsha L Smith, Claudio Agostinelli, Stefano A Pileri, Jordan N Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P Beaver, Alexander Pan, Kyle Shin, Charles T Gregory, Gulcin H Ozer, Selen A Yilmaz, Bonnie K Harrington, Amy M Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly S Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer A Woyach, James S Blachly, Lapo Alinari, Yiping Yang, John C Byrd, Robert A Baiocchi, Bradley W Blaser, Rosa Lapalombella
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. Nature communications 14 (1) (2023)
Giovanna Merchand-Reyes, Ramasamy Santhanam, Maria L Valencia-Pena, Krishan Kumar, Xiaokui Mo, Tesfaye Belay, Jennifer A Woyach, Bethany Mundy-Bosse, Susheela Tridandapani, Jonathan P Butchar
Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia. Nutrients 15 (24) (2023)
Giovanna Merchand-Reyes, Ramasamy Santhanam, Maria L Valencia-Pena, Krishan Kumar, Xiaokui Mo, Tesfaye Belay, Jennifer A Woyach, Bethany Mundy-Bosse, Susheela Tridandapani, Jonathan P Butchar
Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia. Nutrients 15 (24) (2023)
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B Cempre, Fiona Brown, Porsha L Smith, Claudio Agostinelli, Stefano A Pileri, Jordan N Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P Beaver, Alexander Pan, Kyle Shin, Charles T Gregory, Gulcin H Ozer, Selen A Yilmaz, Bonnie K Harrington, Amy M Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly S Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer A Woyach, James S Blachly, Lapo Alinari, Yiping Yang, John C Byrd, Robert A Baiocchi, Bradley W Blaser, Rosa Lapalombella
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. Nature communications 14 (1) (2023)
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A Burger
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 15 (2) (2023)
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A Burger
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 15 (2) (2023)
Zachary A Hing, Janek S Walker, Ethan C Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B Cempre, Fiona Brown, Porsha L Smith, Claudio Agostinelli, Stefano A Pileri, Jordan N Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P Beaver, Alexander Pan, Kyle Shin, Charles T Gregory, Gulcin H Ozer, Selen A Yilmaz, Bonnie K Harrington, Amy M Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly S Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer A Woyach, James S Blachly, Lapo Alinari, Yiping Yang, John C Byrd, Robert A Baiocchi, Bradley W Blaser, Rosa Lapalombella
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation. Nature communications 14 (1) (2023)
Audrey M Sigmund, Ying Huang, Amy S Ruppert, Kami Maddocks, Kerry A Rogers, Samantha M Jaglowski, Seema A Bhat, Adam S Kittai, Michael R Grever, John C Byrd, Jennifer A Woyach
Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib. Leukemia 36 (8) (2022)
Kerry A Rogers, Jennifer A Woyach
A CAPTIVATE-ing new regimen for CLL. Blood 139 (22) (2022)
Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, John C Byrd
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. Leukemia 36 (4) (2022)
Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond, John C Byrd, Daniel Goldstein, Michael R Grever, Cecelia Miller, Kerry A Rogers, Max Yano, Jennifer A Woyach
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib. American journal of hematology (2022)
Jonathan Mitry Hyak, Ying Huang, Kerry A Rogers, Seema A Bhat, Michael R Grever, John C Byrd, Adam S Kittai, Daniel M Jones, Cecelia R Miller, Jennifer A Woyach
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes. Blood advances 6 (17) (2022)
Jennifer A Woyach
Management of relapsed/refractory Chronic Lymphocytic Leukemia. American journal of hematology (2022)
Steven Sher, Ethan C Whipp, Janek Walker, Pu Zhang, Larry Beaver, Katie Williams, Shelley J Orwick, Janani Ravikrishnan, Brandi Walker, Elizabeth Perry, Charles T Gregory, Matthew Purcell, Alexander Pan, Pearlly S Yan, Lapo Alinari, Amy J Johnson, Melanie M Frigault, Joy M Greer, Ahmed Hamdy, Raquel Izumi, Xiaokui M Mo, Deepa Sampath, Jennifer A Woyach, James S Blachly, John C Byrd, Rosa Lapalombella
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. Leukemia (2022)
Sophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, Rozbeh Jafari, Ioannis Siavelis, Matthias Stahl, Eva C Schitter, Nora Liebers, Berit J Brinkmann, Felix Czernilofsky, Tobias Roider, Peter-Martin Bruch, Murat Iskar, Adam Kittai, Ying Huang, JunYan Lu, Sarah Richter, Georgios Mermelekas, Husen Muhammad Umer, Mareike Knoll, Carolin Kolb, Angela Lenze, Xiaofang Cao, Cecilia Österholm, Linus Wahnschaffe, Carmen Herling, Sebastian Scheinost, Matthias Ganzinger, Larry Mansouri, Katharina Kriegsmann, Mark Kriegsmann, Simon Anders, Marc Zapatka, Giovanni Del Poeta, Antonella Zucchetto, Riccardo Bomben, Valter Gattei, Peter Dreger, Jennifer A Woyach, Marco Herling, Carsten Muller-Tidow, Richard Rosenquist, Stephan Stilgenbauer, Thorsten Zenz, Wolfgang Huber, Eugen Tausch, Janne Lehtiö, Sascha Dietrich
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia. Nature communications 13 (1) (2022)
Jennifer A Woyach, Alessandra Tedeschi, Talha Munir, Tanya Siddiqi, Peter Hillmen, John C Byrd, Paolo Ghia, Stephen P Mulligan, Sandra Dai, Carlos I Amaya-Chanaga, James P Dean, Susan M O'Brien, Paul M Barr
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia & lymphoma 62 (13) (2021)
Janek S Walker, Zachary A Hing, Steven Sher, James Cronin, Katie Williams, Bonnie Harrington, Jordan N Skinner, Casey B Cempre, Charles T Gregory, Alexander Pan, Max Yano, Larry P Beaver, Brandi R Walker, Jadwiga M Labanowska, Nyla A Heerema, Krzysztof Mrózek, Jennifer A Woyach, Amy S Ruppert, Amy Lehman, Hatice Gulcin Ozer, Vincenzo Coppola, Pearlly S Yan, John C Byrd, James S Blachly, Rosa Lapalombella
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia. Nature communications 12 (1) (2021)
Amy S Ruppert, Allison M Booth, Wei Ding, Nancy L Bartlett, Danielle M Brander, Steven Coutre, Jennifer R Brown, Sreenivasa Nattam, Richard A Larson, Harry Erba, Mark R Litzow, Carolyn Owen, Charles S Kuzma, Jeremy S Abramson, Richard F Little, Scott E Smith, Richard M Stone, John C Byrd, Sumithra J Mandrekar, Jennifer A Woyach
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202. Leukemia 35 (10) (2021)
Cecelia R Miller, Ying Huang, Amy S Ruppert, Jadwiga Labanowska, Samantha M Jaglowski, Kami J Maddocks, Kerry A Rogers, Seema Bhat, Adam S Kittai, Michael Grever, Rosa Lapalombella, Lynne V Abruzzo, Nyla A Heerema, John C Byrd, Erin K Hertlein, Jennifer A Woyach
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients. Leukemia 35 (11) (2021)
Andrew Rogers, Jennifer A Woyach
BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL. Therapeutic advances in hematology 11 (2020)
Elizabeth M Kander, Qiuhong Zhao, Seema A Bhat, Jessica Hirsch, John C Byrd, Lauren Ooka, Tracy Wiczer, Jennifer A Woyach, Farrukh T Awan, Kerry A Rogers, Tzu-Fei Wang
Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib. British journal of haematology 187 (3) (2019)
Kerry A Rogers, Ying Huang, Emily Dotson, Jordan Lundberg, Leslie A Andritsos, Farrukh T Awan, Jennifer A Woyach, John C Byrd
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre. British journal of haematology 185 (2) (2018)